Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-02 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
F | Common Stock | D | 444 | $182.95 - $182.95 | $81,229 |
2024-03-18 | REPLIGEN CORP | Pax Margaret
(Director) |
A | Common Stock | A | 92 | $0.00 - $0.00 | $0 |
2024-03-11 | REPLIGEN CORP | KURIYEL RALF
(Senior VP, R&D) |
S | Common Stock | D | 3517 | $193.73 - $193.73 | $681,348 |
2024-03-11 | REPLIGEN CORP | KURIYEL RALF
(Senior VP, R&D) |
M | Common Stock | A | 1271 | $86.10 - $86.10 | $109,433 |
2024-03-08 | REPLIGEN CORP | Hunt Anthony
(Chief Executive Officer) |
S | Common Stock | D | 16707 | $195.49 - $202.55 | $3,298,626 |
2024-03-08 | REPLIGEN CORP | Hunt Anthony
(Chief Executive Officer) |
M | Common Stock | A | 1 | $16.55 - $16.55 | $16 |
2024-03-07 | REPLIGEN CORP | Hunt Anthony
(Chief Executive Officer) |
F | Common Stock | D | 2867 | $195.72 - $195.72 | $561,129 |
2024-03-07 | REPLIGEN CORP | KURIYEL RALF
(Senior VP, R&D) |
F | Common Stock | D | 386 | $195.72 - $195.72 | $75,547 |
2024-03-04 | REPLIGEN CORP | Hunt Anthony
(Chief Executive Officer) |
F | Common Stock | D | 8386 | $193.99 - $195.52 | $1,637,930 |
2024-03-04 | REPLIGEN CORP | Gebski Christine
(See Remarks) |
F | Common Stock | D | 131 | $193.99 - $193.99 | $25,412 |
2024-03-04 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
F | Common Stock | D | 219 | $193.99 - $195.52 | $42,517 |
2024-03-04 | REPLIGEN CORP | KURIYEL RALF
(Senior VP, R&D) |
F | Common Stock | D | 135 | $193.99 - $193.99 | $26,188 |
2024-03-01 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
A | Common Stock | A | 50 | $0.00 - $0.00 | $0 |
2024-03-01 | REPLIGEN CORP | KURIYEL RALF
(Senior VP, R&D) |
F | Common Stock | D | 453 | $191.79 - $191.79 | $86,880 |
2024-02-29 | REPLIGEN CORP | KURIYEL RALF
(Senior VP, R&D) |
A | Common Stock | A | 404 | $0.00 - $0.00 | $0 |
2024-03-01 | REPLIGEN CORP | Hunt Anthony
(Chief Executive Officer) |
F | Common Stock | D | 3322 | $191.79 - $191.79 | $637,126 |
2024-02-29 | REPLIGEN CORP | Hunt Anthony
(Chief Executive Officer) |
A | Common Stock | A | 2504 | $0.00 - $0.00 | $0 |
2024-03-01 | REPLIGEN CORP | Gebski Christine
(See Remarks) |
F | Common Stock | D | 908 | $191.79 - $192.71 | $174,569 |
2024-02-29 | REPLIGEN CORP | Gebski Christine
(See Remarks) |
A | Common Stock | A | 391 | $0.00 - $0.00 | $0 |
2024-03-01 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
F | Common Stock | D | 820 | $191.79 - $191.79 | $157,267 |
2024-02-29 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
A | Common Stock | A | 404 | $0.00 - $0.00 | $0 |
2024-02-27 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
A | Common Stock | A | 8691 | $0.00 - $0.00 | $0 |
2024-02-27 | REPLIGEN CORP | Hunt Anthony
(Chief Executive Officer) |
A | Common Stock | A | 19719 | $0.00 - $0.00 | $0 |
2024-02-27 | REPLIGEN CORP | KURIYEL RALF
(Senior VP, R&D) |
A | Common Stock | A | 3520 | $0.00 - $0.00 | $0 |
2024-02-27 | REPLIGEN CORP | Garland Jason K
(CFO) |
A | Common Stock | A | 2540 | $0.00 - $0.00 | $0 |
2024-02-27 | REPLIGEN CORP | Loeillot Olivier
(President and CCO) |
A | Common Stock | A | 2880 | $0.00 - $0.00 | $0 |
2024-02-27 | REPLIGEN CORP | DAWES KAREN A
(Director) |
S | Common Stock | D | 1000 | $193.35 - $193.35 | $193,350 |
2024-02-27 | REPLIGEN CORP | DAWES KAREN A
(Director) |
M | Common Stock | A | 4626 | $42.07 - $42.07 | $194,615 |
2024-02-23 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
S | Common Stock | D | 4373 | $198.08 - $198.08 | $866,203 |
2024-02-23 | REPLIGEN CORP | Bylund James
(Chief Operating Officer) |
M | Common Stock | A | 940 | $94.33 - $94.33 | $88,670 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |